台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    27.65
  • 漲跌
    ▲0.15
  • 漲幅
    +0.55%
  • 成交量
    591
  • 產業
    上市 生技醫療類股
  • 635人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/11 ~ 2024/04/25     後一日»

券商獲利排行 - 2024/04/11 ~ 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.40%1,468.41,709-240.65502,1471,59728.528.129.227.7
  4.86%284.541.7242.810922912025.525.425.827.7
  2.93%156.70156.7-188018828.5028.527.7
  5.75%156.466.190.3-60359528.627.329.227.7
  2.46%135.734.3101.4135204692726.927.427.7
  6.83%135.320.5114.7-52146729.628.329.827.7
  2.59%129.20.1129.1-1314217428.628.628.627.7
  4.02%124.9121.33.614111972827.428.627.7
  10.59%115.6115.60039392826.529.427.7
  0.90%114.2148.9-34.7-29717046727.326.727.527.7
  2.66%107.7116.3-8.6461439728.327.82927.7
  2.27%101.28219.2-887316227.526.727.927.7
  1.59%100.483.716.7-12210723027.52727.827.7
  4.09%100.259.540.7-58308827.826.428.427.7
  4.04%97.813.884-64208428.828.32927.7
  4.36%95.210.185.27782526.726.528.627.7
  5.00%94.815.978.9-6066628.726.32927.7
  4.91%94.36727.3-23456828.227.328.827.7
  5.30%92.750.442.3-37256228.226.828.827.7
  8.85%90.725.565.3-2963529.325.729.927.7
  5.77%86.755.63130552527.326.628.827.7
  5.44%85.91174.9-41125429.328.529.427.7
  4.72%84.94539.8-41236428.126.728.627.7
  8.79%81.445.436-1616322927.129.927.7
  7.31%7963.615.41040302726.128.227.7
  7.19%77.542.335.2-22153828.426.429.227.7
  0.22%7015.254.8-2958601,15627.827.827.827.7
  3.28%69.251.218-19557528.227.628.527.7
  2.40%69.163.65.571069927.226.927.527.7
  0.24%68.865.73.1-2907281,01827.627.627.727.7
  10.73%66.664.622222028.226.729.927.7
  5.19%66.323.742.6-23204429.128.229.427.7
  2.14%63.957.36.6-198910827.727.42827.7
  5.29%60.820.340.5-28124028.727.429.127.7
  4.14%52.541.411-11344528.127.428.727.7
  5.25%52.328.32419371826.926.42827.7
  2.13%49.137.11216856927.126.927.427.7
  3.94%4936.612.421452427.627.128.627.7
  5.89%46.921.825.116301426.626.127.627.7
  4.56%46.234.711.5-11253628.127.328.727.7
  7.29%45.713.731.91524826.125.727.427.7
  5.01%45.434.810.712332027.526.828.627.7
  5.10%43.717.526.3-18113028.627.42927.7
  4.19%43.73.440.2-287362928.52927.7
  3.49%42.69.133.5-3674328.427.328.627.7
  3.69%41.834.27.5-16254127.626.828.127.7
  1.33%41.3-1.642.9681154727272727.7
  2.73%39.72811.721533227.427.12827.7
  9.44%39.439.400151527.826.529.127.7
  2.26%39.136.82.2-13506327.527.127.827.7

券商虧損排行 - 2024/04/11 ~ 2024/04/25

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -6.10%-332.9-69.8-263.1-1673920726.427.926.127.7
  -2.61%-227.4-66.6-160.82233098628.228.427.627.7
  -6.82%-224.1-10.9-213.2104111729.629.728.127.7
  -2.85%-218.3-95.5-122.8-12216328526.927.226.627.7
  -6.08%-191.3-188.8-2.5-129911128.329.327.427.7
  -6.35%-177.9-171.7-6.25100952828.927.127.7
  -1.17%-173.16.9-180-4984654427.327.127.327.7
  -4.13%-113.8-91.1-22.731996827.828.42727.7
  -4.11%-104-6.1-97.9-9329526.729.726.627.7
  -4.57%-101.3-26.9-74.4-60228326.727.726.427.7
  -1.14%-99.2-112.613.43932028127.127.326.927.7
  -7.27%-93-2.8-90.14243129.729.82727.7
  -5.86%-89.5-64.5-25-23335627.328.526.627.7
  -3.52%-85.1-9.8-75.3-8469026.928.426.827.7
  -3.08%-84.9-79.8-5.19999027.828.227.327.7
  -5.06%-82.8-72.5-10.35575128.729.427.927.7
  -3.46%-82.2-82.90.8488842727.526.527.7
  -6.35%-79.9-79.3-0.60444527.928.927.127.7
  -1.28%-78.4-48.9-29.5-1645822227.628.327.527.7
  -6.12%-78.1-19.5-58.63344102929.427.427.7
  -4.31%-77.2-71.7-5.4-7576527.628.22727.7
  -7.88%-69.8-67.3-2.6-1333426.127.125.127.7
  -0.88%-62.3-25-37.4-6020326327.127.22727.7
  -6.10%-62.2-54.8-7.45363128.329.127.427.7
  -4.15%-60.8-12.6-48.138511328.728.927.927.7
  -3.37%-59.9-56.4-3.421654427.327.826.527.7
  -1.95%-59.6-29.3-30.3-882311127.528.627.327.7
  -3.53%-58.4-11.5-46.946581228.528.727.727.7
  -3.53%-56.2-12.2-4445561128.428.627.527.7
  -4.97%-55.7-14.5-41.23039928.72927.427.7
  -2.95%-53.6-9.9-43.654641028.328.527.527.7
  -3.55%-52-9.2-42.836511528.728.828.227.7
  -5.76%-51.7-50.5-1.2132312828.827.227.7
  -8.54%-51.5-44.6-6.9-5172227.428.926.327.7
  -3.65%-48.7-31.5-17.21046362929.428.527.7
  -3.90%-48.1-40.1-8-10344527.428.126.927.7
  -4.92%-47-46-1.1-4303428.128.927.427.7
  -4.80%-46.2-20.8-25.421341228.328.827.127.7
  -4.11%-44.1-32.1-1211382728.228.727.627.7
  -5.53%-43.4-36.8-6.5528222828.727.127.7
  -2.84%-41.7-32.7-9.119533427.828.127.227.7
  -4.84%-41.6-10.9-30.72430628.628.927.127.7
  -6.78%-40.6-40.600212128.529.427.527.7
  -4.38%-39.7-24.7-1512321928.328.827.527.7
  -4.17%-39.2-15.5-23.612322029.329.628.827.7
  -8.56%-38.4-18.2-20.2-971726.428.225.627.7
  -4.00%-38.10-38.13233128.828.828.927.7
  -4.01%-37.1-36.8-0.32343127.227.826.627.7
  -1.83%-35.9-20.4-15.525704528.128.327.827.7
  -3.84%-35.9-19.5-16.316331728.328.727.527.7
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章